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CASE REPORT
Adult-onset Still’s disease (AOSD) is an uncom-
mon systemic inflammatory disorder of unknown
etiology that was first described by Bywaters in
1971.1 Its clinical features classically include pro-
longed fever of unknown origin, evanescent skin
rash, and arthritis. Other tissues or organs might
be affected too. The clinical course of AOSD gen-
erally is benign. Although mild liver involve-
ment is observed frequently in AOSD, severe
jaundice is a rare complication.2 Hemophago-
cytic syndrome (HS) is a rare but potentially fatal
condition, which is characterized by acute fever,
hepatosplenomegaly, lymphadenopathy, pancyto-
penia, and raised levels of serum ferritin, triglyc-
erides, and liver enzymes.3 Causes of secondary
HS phenomenon are diverse, and most com-
monly, it is caused by viral illness, malignancy, or
systemic autoimmune diseases. Excessive produc-
tion of pro-inflammatory cytokines and active in-
filtration of macrophages into vital organs have
been observed in AOSD and HS,4,5 which indi-
cates that AOSD and HS might be included among
the causes of macrophage activation syndrome
(MAS). MAS is a severe and potentially life-threat-
ening complication of chronic rheumatic dis-
eases, which is reported frequently in childhood.
Several pieces of evidence suggested that MAS be-
longs to the secondary or reactive HS, and we
propose to rename it according to the contempo-
rary classification of histiocytic disorders, al-
though the relationship between the two
diseases remains to be determined.6 All these
disease entities share clinical and biochemical
features with the so-called systemic inflammatory
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Hemophagocytic syndrome (HS) that occurs in the course of adult-onset Still’s disease (AOSD) has been
reported only rarely in the literature. HS and AOSD share overlapping clinical and laboratory features,
therefore, it is difficult to recognize HS as a complication of AOSD. Here, we report the case of a 46-year-
old woman with classical features of AOSD. Severe pancytopenia and jaundice associated with extreme
hyperferritinemia occurred during high-dose steroid treatment. Bone marrow biopsy showed typical
pathological features of hemophagocytosis, which confirmed the coexistence of HS with AOSD. The pa-
tient was treated with methylprednisolone pulse therapy of 500 mg/day for 3 days, as recommended in
cases of HS complicating AOSD, and her condition improved gradually. During the disease course, exten-
sive studies could not identify any viral infection or other known underlying etiology for the reactive he-
mophagocytosis. Currently, the patient is in remission on low-dose prednisolone and azathioprine. 
[J Formos Med Assoc 2010;109(1):85–88]
Key Words: adult-onset Still’s disease, hemophagocytic syndromes, jaundice
response syndrome.7 HS that occurs in the course
of AOSD has been reported only rarely. Here, we
report a case of a 46-year-old woman with AOSD
who developed HS during steroid treatment.
Case Report
A 46-year-old woman was admitted on January 21,
2007 because of intermittent spiking fever up to
39.8°C for several months. She had been healthy
until September 2008, when she began to have
fever, sore throat, bilateral shoulder pain, gener-
alized myalgia, and painful swelling in the right
knee. She visited the outpatient clinic, and showed
only short-term improvement. Clinical examina-
tion of the patient revealed mild, decreased breath-
ing sounds over the right lower lung. Morbiliform
papules and macules over the abdomen, trunk, and
both arms developed during fever. Skin biopsy
showed mild perivascular lymphocyte infiltration
in the upper dermis (Figure 1). Serological tests
for autoimmune diseases, including antinuclear
antibody, anti-double-stranded DNA antibody,
anti-mitochondrial antibody, anti-smooth mus-
cle antibody, and rheumatoid factor were negative.
In the work-up of infectious diseases, a variety of
laboratory examinations were performed, which
included hepatitis A, B, C, and E, Epstein–Barr
virus, cytomegalovirus, varicella–zoster virus,
human immunodeficiency virus, herpes simplex
virus, Rickettsia tsutsugamushi, toxoplasmosis,
and Q-fever. The results were all negative. She had
a white blood cell (WBC) count of 10,140/μL
(normal, 4000–10,000/μL), a very high ferritin
level of 10,190 ng/mL (normal, 6–283 ng/mL), a
erythrocyte sedimentation rate of 75 mm/hour
(normal, 0–20 mm/hour), and C-reactive pro-
tein of 21.96 mg/dL (normal, < 0.47 mg/dL) were
noted. Chest X-ray showed blunting of the right
costophrenic angle. Abdominal computed tomog-
raphy showed ascites over the pelvis and minimal
bilateral pleural effusion. Gallium 67 scan for in-
flammation showed increased radioactivity in
both shoulders, elbows, wrists, and hips, which
implied the presence of polyarthritis.
The results of repeated blood and urine cul-
tures were not diagnostic, and empirical systemic
antibiotics did not improve the symptoms. A
clinical diagnosis of AOSD was made based on
spiking fever, skin rash, arthritis, and hyperfer-
ritinemia, in the absence of connective tissue dis-
eases, infectious diseases, and malignancy. She
was treated with 100 mg hydrocortisone every 8
hours, and fever, arthritis, skin rash, and ascites
soon subsided. However, jaundice developed and
progressed daily, with a peak total bilirubin level
of up to 14.14 mg/dL. Simultaneous abnormal
liver function tests included: elevated alanine
aminotransferase (767 U/L; normal, 0–40 U/L),
aspartate aminotransferase (930 U/L; normal,
10–35 U/L), alkaline phosphatase (915 U/L; nor-
mal, 66–240 U/L), r-glutamyltransferase
(377 U/L; normal, 0–60 U/L), prothrombin time
(17.3 seconds; normal, 10.2–12.5 seconds), and
triglyceride (248 mg/dL; normal, 0–150 mg/dL).
Recurrent fever associated with pancytopenia
(WBC count, 1144/μL; platelet count, 82,000/μL;
and red blood cell count, 3.78×106/μL) developed
15 days after high-dose steroid therapy. Ferritin
level increased up to 44,395 ng/mL. Bone mar-
row examination was done and showed marked
hypocellularity (10–20%) with an myeloid to ery-
throid ratio of 26:1, and characteristic hemo-
phagocytosis with few histiocytes engulfing the
hematopoietic cells. No abnormal lymphocytes
in the bone marrow were found. As shown in
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Figure 1. Skin biopsy demonstrated mild perivascular
round-cell infiltration in the dermis; many of them were
histiocytes (arrows; hematoxylin and eosin stain, 400×).
Figure 2, there was an increase in the number of
histiocytes that phagocytosed red cells and their
precursors. Reactive HS was diagnosed and
pulsed methylprednisone at 500 mg/day was
given for three consecutive days. Her fever sub-
sided gradually, together with improvement and
normalization of platelet and WBC counts.
Extensive studies could not identify any evidence
of viral infection or other known underlying dis-
orders associated with reactive HS. Currently, the
patient is in remission with low-dose pred-
nisolone plus azathioprine, and she is undergo-
ing regular outpatient follow-up.
Discussion
We have presented a case of AOSD complicated
with HS. Our patient had intermittent high spik-
ing fever for several months, arthritis, evanescent
rash, leukocytosis, sore throat, abnormal liver func-
tion, and was negative for rheumatoid factor, 
antinuclear antibody, and hyperferritinemia. The
clinical features fulfilled the diagnostic criteria for
AOSD, including four major and three minor cri-
teria.8 AOSD is regarded as a systemic inflamma-
tory disease. Mild liver involvement is observed
frequently in AOSD, but severe jaundice is a rare
manifestation. In our case, jaundice developed and
progressed despite significant improvement of
other clinical features of AOSD, during high-dose
steroid treatment. Other causes of liver disease,
such as viral, autoimmune, hereditary and vascu-
lar disorders were excluded and no evidence of
toxic hepatitis was obtained. Thus, AOSD-related
liver decompensation was considered in our
case. AOSD-related liver failure during treatment
with corticosteroids has been reported rarely in
the literature.2 Another possible cause for severe
jaundice in our case was secondary HS.
The etiology of HS has been reported to be 
associated with viral or bacterial infection, as well
as malignancy and autoimmune rheumatic dis-
eases.9 In our case, diagnosis of active infections
or systemic autoimmune diseases was not estab-
lished by repeated cultures and a variety of sero-
logical tests. There was no evidence of malignancy
through examination of tumor markers, computed
tomography, and gallium scanning. HS was con-
firmed by bone marrow examination in our case.
HS during the course of AOSD has been reported
only rarely.10,11 However, a prevalence of up to
12% has been shown in one study, and reactive
HS can occur at any time during the clinical
course of AOSD.12 HS and AOSD share several
clinical and laboratory features, such as high fever,
hepatosplenomegaly, liver injury, hyperferritine-
mia and coagulopathy, therefore, there is always
difficulty in recognizing HS complicating AOSD.
Thus, HS associated with AOSD is probably under-
diagnosed and more common than recognized
previously.12 However, our patient with AOSD
Still’s disease with hemophagocytic syndrome
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Figure 2. (A) Bone marrow biopsy showed moderate histiocytosis with erythrophagocytosis (arrows; hematoxylin and
eosin stain, 400×). (B) Bone marrow smear depicted a histiocyte engulfing the hematopoietic cells, predominantly red
cells (Liu stain, 1000×).
had a much higher ferritin level (up to
44,395 mg/L), compared with a mean level of
4753 mg/L in a large study of patients with
AOSD.13 One study has suggested that markedly
elevated serum ferritin levels in AOSD might re-
flect the presence of histiocytic hyperactivity and
imply the presence of HS. A further bone marrow
study was indicated.14 According to one study by
Ravelli et al,15 one of the variables with high sen-
sitivity and specificity for reactive HS in systemic-
onset juvenile idiopathic arthritis is serum ferritin
level > 10,000 mg/L. Besides, leukocytosis is a pro-
minent feature of AOSD. When leukopenia and
thrombocytopenia develop in the course of AOSD,
it should raise the possibility of HS.
There is no consensual treatment for HS in
AOSD. In our case, pulse steroid therapy gradually
improved jaundice and pancytopenia. Most re-
ported cases of HS complicating AOSD have re-
sponded well to high-dose corticosteroid therapy.
Other successful therapy has included intravenous
immunoglobulin,12 low-dose methotrexate16 and
cyclophosphamide,17 and plasma exchange.18
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